MedPath
TGA Approval

ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled pen (317262)

317262

ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled pen

Takeda Pharmaceuticals Australia Pty Ltd

May 12, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/6aee65ecaf52ebb897d8e040221a2e77.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/3fc040fac72ea9195d5b9867d35b0858.pdf

Active Ingredients

vedolizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled pen (317262) - TGA 批准文号 | MedPath